• Home
  • Ongoing Clinical Studies

Ongoing Clinical Studies

Filter Clinical Studies by:

Name

Physician(s)

all-types

Name

A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation ›

Physician(s)

Troy H. Guthrie, Jr., MD

Name

Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice ›

Physician(s)

Troy H. Guthrie, Jr., MD

Bladder Cancer

Name

A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging ›

Physician(s)

John Vito Antonucci, MD
Jeffrey D. Forman, MD
Michael I. Ghilezan, MD, PhD
Larry L. Kestin, MD
Alvaro A. Martinez, MD, FACR
Frank A. Vicini, MD
Patrick M. Francke, MD, FACRO
Stephen F. Andrews, DO
Ajay Bhatnagar, MD, MBA

Breast Cancer

Name

ASBrS Nipple Sparing Mastectomy Registry ›

Physician(s)

David T. Rock, MD, FACS

Name

Employing objective methods to compare cosmetic outcomes between minority and non-minority women after breast conservation therapy. ›

Physician(s)

Sophia Edwards-Bennett, MD, PhD, DABR®

Name

MROQC ›

Physician(s)

Larry L. Kestin, MD

Name

Prospective Neo-Adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial ›

Physician(s)

David T. Rock, MD, FACS

Name

Tri-fraction Radiotherapy Utilized to Minimize Patient Hospital Trips: A Phase II Trial (TRIUMPH-T Trial) ›

Physician(s)

Frank A. Vicini, MD

Gastric Cancer

Name

Randomized, Double-Blind, Phase 3 Study Evaluating Tas-102 Plus Best Supportive Care (Bsc) Versus Placebo Plus Bsc In Patients With Metastatic Gastric Cancer Refractory To Standard Treatments ›

Physician(s)

Troy H. Guthrie, Jr., MD

Gynecologic Cancers

Name

A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Recurrent Gynecologic Malignancy ›

Physician(s)

Back
To top